Generics 48

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Erlotinib manufacturers

48 products found

Filters

48 products found

erlotinib

Tablets, film coated 25mg, 100mg, 150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Saudi Arabia
Registered in
Cyprus
Manufacturer #370
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 20+ years. Key production lines are Rx and OTC. Main therapeutic areas include oncology, urology, and antivirals. The company's production lines are GMP-compliant. The company possesses branches in the Middle East and Asia.

Manufacturer usually replies in 3 days

erlotinib

Tablets, film coated 25 mg, 50 mg, 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

erlotinib

Tablets 100, 150mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12186
The activity of the company is based on the development of highly competitive processes for the manufacture of active ingredients with high added value that meet the strictest quality specifications. They manufacture under strict compliance with the environmental and occupational safety regulations in force in Europe. They focus on the pharmaceutical, hospital, diagnostic, fine chemical, and food fields. Its products are marketed in more than 70 countries.

Manufacturer usually replies in 7 days

erlotinib

Tablets 25 mg, 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
MAs for sale
Netherlands
Manufacturer #276

Manufacturer usually replies in 1 days

erlotinib

Tablets 25mg, 100mg, 150mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #403

erlotinib

Tablets, film coated 25 mg, 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Bulgaria , Costa Rica , Vietnam , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Registered in
Turkey
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

erlotinib

Tablets, film coated 25 mg, 100 mg, 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days

erlotinib

Tablets 150mg, 100mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, ANVISA
Manufacturer #9406

Manufacturer usually replies in 7 days

erlotinib

Tablets 25 mg, 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Tarceva (Roche)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

erlotinib

Tablets, film coated 25 mg, 100 mg, 150 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18852

Manufacturer usually replies in 16 days

erlotinib

Tablets, film coated 25mg, 100mg, 150mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, SA, UA
Unavailable markets
Costa Rica , Ukraine , Vietnam , Albania , Bosnia And Herzegovina , Kosovo , Serbia , Slovenia
Manufacturer #361

It is a global player with more than half a century of experience. It has more than 4 facilities to operate from. They have marketing and promotion in more than 20 countries. It exports to more than 50 countries. The only motto is to improve the quality of human life and to provide access to reliable, high-quality products for human health worldwide. It is focused to create its own cadres in every country it operates.

Manufacturer usually replies in 9 days

erlotinib

Tablets 100 mg , 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

erlotinib

Tablets 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

erlotinib

Tablets 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

erlotinib

Tablets 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

erlotinib

Tablets 25 mg, 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18530

Manufacturer usually replies in 4 days

erlotinib

Tablets, film coated TBD

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

erlotinib

Tablets 100mg/150mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #13622

Manufacturer usually replies in 6 days

erlotinib

Tablets 100 mg, 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

erlotinib

Tablets 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

Want to view all 48 products? Create your free account today!

Erlotinib Manufacturers

Erlotinib is a medication used to treat non-small cell lung cancer and pancreatic cancer. Erlotinib suppliers and distributors market the drug in the form of 25mg, 100mg, 150mg oral tablets. The developer and earliest erlotinib manufacturer was Roche, who first acquired approval to market the drug in 2004. Currently, the medication is available in over 50 countries worldwide and is included on the World Health Organisation’s list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Erlotinib suppliers in the U.S are OSI Pharma and Genentech, whereas across all of the other geographical markets, erlotinib is supplied by Roche. Other major erlotinib manufacturers and suppliers include companies such as Sandoz and Teva. Given that the patent of Roche has since expired, erlotinib suppliers and distributors market both generic and trade name formulations of the drug.

How Does Erlotinib Work?

Erlotinib's clinical antitumor action's method is not completely understood. The phosphorylation of tyrosine kinase linked to the epidermal growth factor receptor intracellularly is inhibited by erlotinib (EGFR). It has not yet been thoroughly described how specifically other tyrosine kinase receptors are inhibited. Both healthy cells and malignant cells express the EGFR protein on their cell surfaces. After being taken orally, erlotinib is only around 60% absorbed, but eating increases its bioavailability to almost 100%. Four hours after medication, peak plasma levels happen. Erlotinib's solubility is pH-dependent. pH rises as solubility falls. Erlotinib exposure is also decreased by smoking. In the liver, metabolism takes place. Erlotinib is largely metabolised by CYP3A4 and to a lesser amount by CYP1A2, as well as the extrahepatic isoform of CYP1A1, according to in vitro tests of cytochrome P450 metabolism.

Wholesale Price of Erlotinib

Costs of erlotinib vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. The retail prices per 30 (100mg) tablets of erlotinib fall into an approximate range of 650 EUR to 1000 EUR, whereas the equivalent amount of 150mg tablets can cost anywhere from 900 EUR to 1,300 EUR. Also the costs of Erlotinib vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Erlotinib is available for sale from various Erlotinib vendors at multiple costs. Erlotinib suppliers, on the whole, are in favor of patient aid initiatives.

From Where to Get Erlotinib?

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Erlotinib manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Erlotinib, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Erlotinib.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Erlotinib offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Erlotinib suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Erlotinib. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Erlotinib is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Erlotinib suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Erlotinib manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.